Micro
Emerging
Archived
VTVT 2025 financial results: net loss and Cadisegliatin advancements
New narrative with limited coverage — still forming.
Score
0.2
Velocity
▲ 0.0
Articles
1
Sources
1
Top Movers
| Ticker | Sector | Change |
|---|---|---|
| Healthcare | -1.6% |
Sentiment Timeline
Sector Performance
Stock Performance
Event Timeline
Mar 19, 2026
vTv Therapeutics (VTVT) Reports $27M 2025 Net Loss Amid Cadisegliatin Advancements
Neutral
Top Movers
| Ticker | Sector | Change |
|---|---|---|
| Healthcare | -1.6% |
Timeline
First SeenMar 19, 2026
Last UpdatedMar 19, 2026